Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Arnab Das: EM, Mexico Fear Trump Saying 'You’re Fired'
41:38 - In today's "Morning Must Read," Bloomberg’s Anna Edwards highlights comments from Morgan Stanley Chief Executive Officer James Gorman on the U.S. presidential election. She speaks with Arnab Das, head of Emerging Markets macro research at Invesco Asset Management, on "Bloomberg Surveillance." (Source: Bloomberg)
  • Arnab Das: In Delicate Phase of 'Dovish' Fed Tightening
  • Phelps: Inflation Expectations Moving up From Low Base
  • Draghi Faces a Euro Problem He Can't Solve, Says French